Molecular Modeling of Protein Corona Formation and Its Interactions with Nanoparticles and Cell Membranes for Nanomedicine Applications

Abstract

The conformations and surface properties of nanoparticles have been modified to improve the efficiency of drug delivery. However, when nanoparticles flow through the bloodstream, they interact with various plasma proteins, leading to the formation of protein layers on the nanoparticle surface, called protein corona. Experiments have shown that protein corona modulates nanoparticle size, shape, and surface properties and, thus, influence the aggregation of nanoparticles and their interactions with cell membranes, which can increases or decreases the delivery efficiency. To complement these experimental findings and understand atomic-level phenomena that cannot be captured by experiments, molecular dynamics (MD) simulations have been performed for the past decade. Here, we aim to review the critical role of MD simulations to understand (1) the conformation, binding site, and strength of plasma proteins that are adsorbed onto nanoparticle surfaces, (2) the competitive adsorption and desorption of plasma proteins on nanoparticle surfaces, and (3) the interactions between protein-coated nanoparticles and cell membranes. MD simulations have successfully predicted the competitive binding and conformation of protein corona and its effect on the nanoparticle–nanoparticle and nanoparticle–membrane interactions. In particular, simulations have uncovered the mechanism regarding the competitive adsorption and desorption of plasma proteins, which helps to explain the Vroman effect. Overall, these findings indicate that simulations can now provide predications in excellent agreement with experimental observations as well as atomic-scale insights into protein corona formation and interactions.

Ligand Ratio Plays a Critical Role in the Design of Optimal Multifunctional Gold Nanoclusters for Targeted Gastric Cancer Therapy

“…It has been demonstrated that PC directly influences the surface chemistry of NDDSs and, consequently, has a strong implication on their targeting abilities . Thus, detailed atomic-level modeling of PC formation would be necessary for further investigations to predict the potential discrepancies between the in vivo and in vitro studies associated with this phenomenon, which are significant challenges to face for most nanomaterials . Further studies also include the characterization at the atomistic scale of the nanosystem–cancer cell receptor interactions to gain insight into the dynamic behavior and possible structural changes of this complex under realistic conditions, as well as the synthesis and characterization of the most promising formulations to be tested experimentally.…”

Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy

“…It has been reported that ZnONPs have potential inhibitory effects on cancer cells due to their inherent toxicity. 140 It can be obtained via resulting intracellular ROS formation and stimulating the apoptotic signaling mechanism. ZnONPs have been demonstrated to enhance the bioavailability of nanomedicine and resulted in the improvement of chemotherapy.…”

“…The uses of ZnONPs as DDSs for loading and delivering hydrophobic anticancer agents are being investigated, and combining it with PBA improves its absorption in tumor tissue via interacting with the sialic acid 140 . In HepG2 cells, ZnONPs also caused caspase‐3 activity, DNA breakage, ROS production, oxidative stress, and according to research ZnONPs specifically triggered apoptosis in cancer cells 142 .…”

Hierarchy of hybrid materials. Part-II: The place of organics-on-inorganics in it, their composition and applications

“…Another problem is the corona effect which requires additional stabilization. This is because when nanoparticles are injected into the intravenous stream, the blood’s proteins would adsorb on the surface of the particles, thus forming a protein corona layer ( Lee, 2021 ). Protein corona may lead to undesirable effects, for example, facilitating or inhibiting cellular uptake and mitigating or stimulating the immune response ( Del Pino et al, 2014 ; Mosquera et al, 2018 ; Liu et al, 2020a ).…”